Clinical trial
Argus® II Retinal Stimulation System Feasibility Protocol
NCT00407602 · Second Sight Medical Products, Industry · Completed
Key facts
| NCT number | NCT00407602 |
|---|---|
| Title | Argus® II Retinal Stimulation System Feasibility Protocol |
| Official title | Argus® II Retinal Stimulation System Feasibility Protocol |
| Lead sponsor | Second Sight Medical Products, Industry |
| Collaborators | National Eye Institute (NEI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa |
| Intervention type | Device |
| Interventions | Implant of Argus II Retinal Prosthesis |
| Enrollment | 30 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 31, 2019 |
| Completion | Dec 31, 2019 |
| First posted | Dec 5, 2006 |
| Last update posted | Jan 20, 2022 |
| Countries | France, Mexico, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: